跳至主要内容
临床试验/NCT07030452
NCT07030452已完成不适用

Effectiveness and Safety of Laser Acupuncture on Pulmonary Function Test and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease)

Indonesia University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Forced Expiratory Volume in One Second (FEV1%)

研究概览

简要总结

This clinical trial aims to evaluate the effectiveness and safety of laser acupuncture as an adjunct therapy in patients with chronic obstructive pulmonary disease (COPD). The main research questions are:

  • Does laser acupuncture, when combined with standard pharmacological treatment, improve lung function (measured by FEV1% and FEV1/FVC ratio) more than sham laser acupuncture after 4 weeks of therapy?
  • Does this combination also lead to better quality of life, as assessed by the COPD Assessment Test (CAT) and the St. George's Respiratory Questionnaire (SGRQ), compared to the control group, after 4 and 8 weeks?
  • Is there a correlation between lung function (FEV1%) and quality of life scores (CAT and SGRQ)?
  • Are there any significant adverse effects caused by laser acupuncture compared to sham treatment?

Participants will:

  • Undergo spirometry and complete CAT and SGRQ questionnaires.
  • Receive either laser acupuncture or sham laser acupuncture sessions.
  • Return for follow-up assessments at 4 and 8 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

盲法说明

Blinding will be applied to participants and outcome assessor. Group allocation will not be disclosed to them to minimize assessment bias

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Diagnosed with stable chronic obstructive pulmonary disease (COPD) based on the Global Initiative for COPD (GOLD).
  • •No acute exacerbation in the last 4 weeks.
  • •Male or female participants aged 20 to 80 years.
  • •Willing to participate in the study until completion and has signed informed consent.

排除标准

  • •History of lung surgery as treatment for COPD.
  • •Psychiatric or cognitive disorders.
  • •Underwent acupuncture within the last 2 weeks.
  • •Pregnant or breastfeeding.
  • •Presence of wounds or skin disorders at the laser acupuncture site.
  • •History of uncontrolled epilepsy.
  • •Fever > 38.0°C.

研究组 & 干预措施

Intervention Group

Experimental

Laser Acupuncture

干预措施: Laser Acupuncture (Device)

Control Group

Sham Comparator

Sham Laser Acupuncture

干预措施: Sham Laser Acupuncture (Device)

结局指标

主要结局

Forced Expiratory Volume in One Second (FEV1%)

时间窗: Baseline and 4 weeks after intervention

Pulmonary function will be assessed using spirometry to measure the percentage of the predicted FEV1 value.

FEV1/FVC Ratio

时间窗: Baseline and 4 weeks after intervention

Pulmonary function will also be evaluated by calculating the FEV1/FVC ratio through spirometry

COPD Assessment Test (CAT) Score

时间窗: Baseline, 4 weeks, and 8 weeks after intervention

Health status and quality of life will be assessed using the CAT questionnaire, which scores from 0 to 40. Higher scores indicate worse health status.

St. George's Respiratory Questionnaire (SGRQ) Score

时间窗: Baseline, 4 weeks, and 8 weeks after intervention

Quality of life will be assessed using the SGRQ, which includes symptom, activity, and impact domains. Scores range from 0 to 100, with higher scores indicating poorer quality of life.

次要结局

  • Correlation Between FEV1% and Quality of Life Scores(Baseline, 4 weeks, and 8 weeks)
  • Adverse Events Related to Intervention(Immediately post-intervention until 8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dwi Lestari Ayuningtyas

Principal Investigator

Indonesia University

研究点 (1)

Loading locations...

相似试验